SI2319517T1 - Use of prodrugs for ocular intravitreous administration - Google Patents
Use of prodrugs for ocular intravitreous administrationInfo
- Publication number
- SI2319517T1 SI2319517T1 SI200631706T SI200631706T SI2319517T1 SI 2319517 T1 SI2319517 T1 SI 2319517T1 SI 200631706 T SI200631706 T SI 200631706T SI 200631706 T SI200631706 T SI 200631706T SI 2319517 T1 SI2319517 T1 SI 2319517T1
- Authority
- SI
- Slovenia
- Prior art keywords
- prodrugs
- ocular
- intravitreous administration
- intravitreous
- administration
- Prior art date
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06290902A EP1864668B1 (en) | 2006-06-01 | 2006-06-01 | Use of prodrugs for ocular intravitreous administration |
| EP10177382.8A EP2319517B1 (en) | 2006-06-01 | 2006-06-01 | Use of prodrugs for ocular intravitreous administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2319517T1 true SI2319517T1 (en) | 2014-01-31 |
Family
ID=49724909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200631706T SI2319517T1 (en) | 2006-06-01 | 2006-06-01 | Use of prodrugs for ocular intravitreous administration |
Country Status (4)
| Country | Link |
|---|---|
| CY (2) | CY1113750T1 (en) |
| ES (1) | ES2437160T3 (en) |
| PT (1) | PT2319517E (en) |
| SI (1) | SI2319517T1 (en) |
-
2006
- 2006-06-01 PT PT10177382T patent/PT2319517E/en unknown
- 2006-06-01 ES ES10177382T patent/ES2437160T3/en active Active
- 2006-06-01 SI SI200631706T patent/SI2319517T1/en unknown
-
2013
- 2013-02-20 CY CY20131100153T patent/CY1113750T1/en unknown
- 2013-11-27 CY CY20131101064T patent/CY1114650T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2437160T3 (en) | 2014-01-09 |
| CY1113750T1 (en) | 2016-06-22 |
| PT2319517E (en) | 2013-11-25 |
| CY1114650T1 (en) | 2016-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1110219A1 (en) | Use of prodrugs for ocular intravitreous administration | |
| EP2005880A4 (en) | Ophthalmologic instrument | |
| GB0610680D0 (en) | Therapeutic compounds | |
| IL193678A0 (en) | Therapeutic compounds | |
| EP2068864A4 (en) | Therapeutic uses of urolithins | |
| GB0603041D0 (en) | Therapeutic compounds | |
| HK1203925A1 (en) | Therapeutic compounds | |
| GB0606663D0 (en) | Therapeutic compounds | |
| IL197235A0 (en) | Therapeutic compositions | |
| GB0615809D0 (en) | Therapeutic compounds | |
| GB0612971D0 (en) | Therapeutic compounds | |
| TWM300818U (en) | Structure for accessory of eyeglasses set | |
| GB0625783D0 (en) | Medicament | |
| GB0625349D0 (en) | Therapeutic compounds | |
| EP2079704A4 (en) | Therapeutic compounds | |
| GB0625345D0 (en) | Therapeutic compounds | |
| GB0615064D0 (en) | Medicament | |
| GB0605573D0 (en) | Therapeutic Compounds | |
| GB0603455D0 (en) | Therapeutic compounds | |
| EP2098245A4 (en) | Use of cholinesterase for manufacturing an anti-tachykinins medicament | |
| SI2319517T1 (en) | Use of prodrugs for ocular intravitreous administration | |
| PT2322183E (en) | Use of prodrugs for ocular intravitreous administration | |
| GB0608269D0 (en) | Therapeutic compounds | |
| GB0615814D0 (en) | Medicament | |
| GB2439923B (en) | Therapeutic compounds |